MX353394B - Aplicación de dihidroxiclorinas beta-funcionalizadas para tfd. - Google Patents
Aplicación de dihidroxiclorinas beta-funcionalizadas para tfd.Info
- Publication number
- MX353394B MX353394B MX2013000877A MX2013000877A MX353394B MX 353394 B MX353394 B MX 353394B MX 2013000877 A MX2013000877 A MX 2013000877A MX 2013000877 A MX2013000877 A MX 2013000877A MX 353394 B MX353394 B MX 353394B
- Authority
- MX
- Mexico
- Prior art keywords
- pdt
- chlorins
- another embodiment
- precursors
- dihydroxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002243 precursor Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000003504 photosensitizing agent Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 208000014001 urinary system disease Diseases 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36670710P | 2010-07-22 | 2010-07-22 | |
| PCT/US2011/047576 WO2012012809A2 (en) | 2010-07-22 | 2011-08-12 | APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013000877A MX2013000877A (es) | 2013-07-03 |
| MX353394B true MX353394B (es) | 2018-01-11 |
Family
ID=45497505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013000877A MX353394B (es) | 2010-07-22 | 2011-08-12 | Aplicación de dihidroxiclorinas beta-funcionalizadas para tfd. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2870159B1 (enExample) |
| JP (1) | JP2013532664A (enExample) |
| CN (1) | CN103097390B (enExample) |
| BR (1) | BR112013001576A2 (enExample) |
| IL (1) | IL224381B (enExample) |
| MX (1) | MX353394B (enExample) |
| PL (1) | PL2870159T3 (enExample) |
| WO (1) | WO2012012809A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103096887B (zh) * | 2010-07-22 | 2017-12-29 | 拜欧利泰克投资二代公司 | 用于抗微生物光动力疗法的糖取代的二羟基‑二氢卟酚和β‑官能化二氢卟酚 |
| WO2013015774A1 (en) | 2011-07-22 | 2013-01-31 | Biolitec Pharma Marketing Ltd | Glyco-substituted dihydroxy-chlorins and b-functionalized chlorins for anti-microbial photodynamic therapy |
| CN103995045A (zh) * | 2014-05-29 | 2014-08-20 | 武汉矽感科技有限公司 | 离子迁移谱仪用于检测乐果和马拉硫磷残留的用途及方法 |
| EP3292129B1 (en) * | 2015-05-07 | 2019-03-27 | Luzitin S.A. | Low molecular weight halogenated porphyrine carboxamide chlorin and bacteriochlorin derivatives for use in photodynamic therapy for treating cancer |
| US9722103B2 (en) | 2015-06-26 | 2017-08-01 | Sunpower Corporation | Thermal compression bonding approaches for foil-based metallization of solar cells |
| CN104940950B (zh) * | 2015-07-09 | 2017-11-28 | 武汉大学 | 一种肿瘤靶向多肽光敏剂键合物 |
| CN111196819B (zh) * | 2018-11-16 | 2023-03-28 | 中国科学院上海药物研究所 | 一类d-a-d型苯并吡嗪类化合物及制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5648485A (en) * | 1994-10-26 | 1997-07-15 | University Of British Columbia | β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins |
| FR2877943B1 (fr) * | 2004-11-16 | 2008-09-05 | Univ De Coimbra | Nouveaux derives de porphyrine, notamment chlorines et/ou bacteriochlorine, et leurs applications en therapie photodynamique |
| US9315510B2 (en) * | 2008-09-18 | 2016-04-19 | Biolitec Pharma Marketing Ltd | Method and application of unsymmetrically meso-substituted porphyrins and chlorins for PDT |
| JP6041360B2 (ja) * | 2011-07-22 | 2016-12-07 | バイオリテック ウンターネーメンスベタイリグンクス ツヴァイ アクツィエンゲゼルシャフト | 抗菌性光線力学療法のための、糖−置換ジヒドロキシ−クロリン及びβ−官能化クロリン |
-
2011
- 2011-08-12 BR BR112013001576A patent/BR112013001576A2/pt not_active Application Discontinuation
- 2011-08-12 PL PL11810524T patent/PL2870159T3/pl unknown
- 2011-08-12 CN CN201180039522.7A patent/CN103097390B/zh active Active
- 2011-08-12 MX MX2013000877A patent/MX353394B/es active IP Right Grant
- 2011-08-12 JP JP2013520904A patent/JP2013532664A/ja active Pending
- 2011-08-12 EP EP11810524.6A patent/EP2870159B1/en active Active
- 2011-08-12 WO PCT/US2011/047576 patent/WO2012012809A2/en not_active Ceased
-
2013
- 2013-01-23 IL IL224381A patent/IL224381B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| PL2870159T3 (pl) | 2018-01-31 |
| CN103097390A (zh) | 2013-05-08 |
| MX2013000877A (es) | 2013-07-03 |
| CN103097390B (zh) | 2017-03-08 |
| JP2013532664A (ja) | 2013-08-19 |
| EP2870159B1 (en) | 2017-06-28 |
| EP2870159A4 (en) | 2015-08-12 |
| EP2870159A2 (en) | 2015-05-13 |
| WO2012012809A2 (en) | 2012-01-26 |
| WO2012012809A3 (en) | 2012-05-18 |
| IL224381B (en) | 2018-03-29 |
| BR112013001576A2 (pt) | 2016-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX353394B (es) | Aplicación de dihidroxiclorinas beta-funcionalizadas para tfd. | |
| MX2010002392A (es) | Composiciones de brimonidina mejoradas para tratar eritema. | |
| EP2350058A4 (en) | NEW METHODS AND USE OF UNSYMMETRIC MESO-SUBSTITUTED PORPHYRINE AND CHLORINE FOR THE PDT | |
| WO2011130753A3 (en) | Functionalized nano- and micro-materials for medical therapies | |
| WO2009050506A3 (en) | Combination 059 | |
| EP3501546A3 (de) | Cystein-wirkstoff konjugate und ihre verwendung | |
| WO2007134245A3 (en) | Elastin-like polymer delivery vehicles | |
| MY168791A (en) | Carbamate compounds and of making and using same | |
| EP4124346A3 (en) | Compositions and methods for treating diseases | |
| WO2013136192A3 (en) | Use of tetracycline compositions for wound treatment and skin restoration | |
| PH12018500641A1 (en) | Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) | |
| WO2011098518A3 (en) | Delivery of immunoglobulin variable domains and constructs thereof | |
| NO20082567L (no) | Kombinasjon av ZD6474 og pemetrexed | |
| NZ601559A (en) | Platelet-derived growth factor compositions and methods for the treatment of tendinopathies | |
| CA2725873A1 (en) | Monoclonal antibodies to basic fibroblast growth factor | |
| WO2013071056A3 (en) | Combination drug therapy for the treatment of solid tumors | |
| CY1111482T1 (el) | Συνδυασμος azd2171 και πεμετρεξεδης | |
| NZ610853A (en) | Phenylketone carboxylate compounds and pharmaceutical uses thereof | |
| WO2005092385A3 (en) | Combination therapy of azd2171 and a taxane | |
| WO2007003933A3 (en) | Combination therapy of cancer with azd2171 and gemcitabine | |
| UA109904C2 (uk) | Комбінована терапія для шкірних розладів | |
| HK1172321A1 (zh) | 3-替代-8-替代-3h咪唑[5，1-d][1，2，3，5]-四嗪-4-酮化合物及其用途 | |
| HK1187812A (en) | Combination treatment for rosacea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG |
|
| FG | Grant or registration |